Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Tectonic Therapeutic (TECX) Shares Issued (2018 - 2026)

Tectonic Therapeutic (TECX) has 9 years of Shares Issued data on record, last reported at $1.3 million in Q1 2026.

On a quarterly basis, Shares Issued rose 30.04% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 40.23% decrease, with the full-year FY2025 number at $1.2 million, down 24.2% from a year prior.
Shares Issued reached $1.3 million in Q1 2026 per TECX's latest filing, up from $59000.0 in the prior quarter.
Over the last five years, Shares Issued for TECX hit a ceiling of $172.1 million in Q2 2025 and a floor of -$171.9 million in Q3 2025.
A 5-year average of $327846.2 and a median of $120000.0 in 2023 define the central range for Shares Issued.
On a YoY basis, Shares Issued climbed as much as 28587.67% in 2025 and fell as far as 223380.52% in 2025.
Tracing TECX's Shares Issued over 5 years: stood at $58000.0 in 2022, then surged by 106.9% to $120000.0 in 2023, then soared by 649.17% to $899000.0 in 2024, then crashed by 93.44% to $59000.0 in 2025, then soared by 2042.37% to $1.3 million in 2026.
Business Quant data shows Shares Issued for TECX at $1.3 million in Q1 2026, $59000.0 in Q4 2025, and -$171.9 million in Q3 2025.